Indian Journal of Pharmaceutical Education and Research logo
Review

Pharm D Program: Is it Necessary in BRICS?

1, 2, 2, 2, 1

  1. 1College of Pharmacy, Jinan University, Guangzhou, CHINA.
  2. 2Faculty of Pharmacy, Rhodes University, Grahamstown, SOUTH AFRICA.

CORRESPONDENCE

Pei Yu

College of Pharmacy, Jinan University, Guangzhou, CHINA.

pennypeiyu@163.com

Received: 30-09-2019; Accepted: 26-02-2020.

Volume 54, Issue 3 · pp. 517-525 · 2020 · DOI: 10.5530/ijper.54.3.100

ABSTRACT

The various trajectories of the development of the Doctor of Pharmacy (Pharm D) programs in BRICS countries were reviewed individually, showing the progress of Pharm D programs in each context. Evidence from developed countries indicates that Pharm D programs have contributed towards the positive development of public health and a country’s local health requirements, with well-trained clinical pharmacists having a key role in the health and economic development of these emerging powers. The health systems of BRICS countries are heavily challenged with a dual burden of disease, weak health infrastructure and public health initiatives. Thus, not only will the development of Pharm D programs in BRICS countries strengthen pharmacy education contributing to a pharmacy workforce more readily able to target health-related problems, demographic and epidemiological shifts; but will also better equip public health systems with more patient-centered pharmaceutical care necessary for evidence-based, individualized and cost-effective healthcare.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Yu, P., Wilson, B. J., Bobbins, A. C., Srinivas, S. C., & Yin, G. (2020). Pharm D Program: Is it Necessary in BRICS?. Indian Journal of Pharmaceutical Education and Research, 54(3), 517-525. https://doi.org/10.5530/ijper.54.3.100

    Copyright and licence

    © 2020 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0